Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Concomitant high-grade prostatic intraepithelial neoplasia is associated with good prognosis factors and oncologic outcome after radical prostatectomy.

Ingels A, Ploussard G, Allory Y, Abbou C, de la Taille A, Salomon L.

Urol Int. 2014;92(3):264-9. doi: 10.1159/000351319. Epub 2013 Aug 1.

PMID:
23919964
2.

High-grade prostatic intraepithelial neoplasia is an independent predictor of outcome after radical prostatectomy.

Pierorazio PM, Lambert SM, Matsukhani M, Sprenkle PC, McCann TR, Katz AE, Olsson CA, Benson MC, McKiernan JM.

BJU Int. 2007 Nov;100(5):1066-70. Epub 2007 Sep 3.

3.

The presence of high-grade prostatic intraepithelial neoplasia or atypia on prostate biopsy does not adversely affect prostatectomy outcomes for patients otherwise eligible for active surveillance.

Pietzak EJ 3rd, Kabarriti AE, Mucksavage P, Bavaria T, Van Arsdalen K, Malkowicz SB, Wein AJ, Guzzo TJ.

Urology. 2014 Dec;84(6):1442-7. doi: 10.1016/j.urology.2014.04.066. Epub 2014 Oct 5.

PMID:
25288572
4.

Significance of perineural invasion, lymphovascular invasion, and high-grade prostatic intraepithelial neoplasia in robot-assisted laparoscopic radical prostatectomy.

Jung JH, Lee JW, Arkoncel FR, Cho NH, Yusoff NA, Kim KJ, Song JM, Kim SJ, Rha KH.

Ann Surg Oncol. 2011 Dec;18(13):3828-32. doi: 10.1245/s10434-011-1790-4. Epub 2011 Jun 10.

PMID:
21660497
5.

Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.

Ploussard G, Agamy MA, Alenda O, Allory Y, Mouracade P, Vordos D, Hoznek A, Abbou CC, de la Taille A, Salomon L.

BJU Int. 2011 Jun;107(11):1748-54. doi: 10.1111/j.1464-410X.2010.09728.x. Epub 2010 Sep 30.

6.

Initial high-grade prostatic intraepithelial neoplasia with carcinoma on subsequent prostate needle biopsy: findings at radical prostatectomy.

Al-Hussain TO, Epstein JI.

Am J Surg Pathol. 2011 Aug;35(8):1165-7. doi: 10.1097/PAS.0b013e3182206da8.

7.

Effect of high-grade prostatic intraepithelial neoplasia on total and percent free serum prostatic-specific antigen.

Morote J, Raventós CX, Encabo G, López M, de Torres IM.

Eur Urol. 2000 Apr;37(4):456-9.

PMID:
10765077
8.

Heterogeneous clinicopathological features of intraductal carcinoma of the prostate: a comparison between "precursor-like" and "regular type" lesions.

Miyai K, Divatia MK, Shen SS, Miles BJ, Ayala AG, Ro JY.

Int J Clin Exp Pathol. 2014 Apr 15;7(5):2518-26. eCollection 2014.

9.

Pathological changes of high-grade prostatic intraepithelial neoplasia and prostate cancer after monotherapy with bicalutamide 150 mg.

Scattoni V, Montironi R, Mazzucchelli R, Freschi M, Nava L, Losa A, Terrone C, Scarpa RM, Montorsi F, Pappagallo G, Rigatti P.

BJU Int. 2006 Jul;98(1):54-8.

10.

Biochemical recurrence after robot-assisted radical prostatectomy in a European single-centre cohort with a minimum follow-up time of 5 years.

Sooriakumaran P, Haendler L, Nyberg T, Gronberg H, Nilsson A, Carlsson S, Hosseini A, Adding C, Jonsson M, Ploumidis A, Egevad L, Steineck G, Wiklund P.

Eur Urol. 2012 Nov;62(5):768-74. doi: 10.1016/j.eururo.2012.05.024. Epub 2012 May 18.

PMID:
22633365
11.

Radical prostatectomy represents an effective treatment in patients with specimen-confined high pathological Gleason score prostate cancer.

Lughezzani G, Gallina A, Larcher A, Briganti A, Capitanio U, Suardi N, Lista G, Abrate A, Sangalli MN, Buffi N, Cestari A, Guazzoni G, Rigatti P, Montorsi F.

BJU Int. 2013 May;111(5):723-30. doi: 10.1111/j.1464-410X.2012.11114.x. Epub 2012 Apr 4.

12.

The role of high-grade prostatic intraepithelial neoplasia for biochemical relapse of prostate carcinoma after radical prostatectomy.

Auskalnis S, Milonas D, Jievaltas M, Vaiciūnas K, Mickevicius A, Gudinaviciene I.

Medicina (Kaunas). 2010;46(9):604-10.

13.

Long-term oncological outcome and risk stratification in men with high-risk prostate cancer treated with radical prostatectomy.

Yamamoto S, Kawakami S, Yonese J, Fujii Y, Urakami S, Masuda H, Numao N, Ishikawa Y, Kohno A, Fukui I.

Jpn J Clin Oncol. 2012 Jun;42(6):541-7. doi: 10.1093/jjco/hys043. Epub 2012 Mar 28.

PMID:
22457326
14.

Effect of neoadjuvant hormonal therapy on prostatic intraepithelial neoplasia and its prognostic significance.

Balaji KC, Rabbani F, Tsai H, Bastar A, Fair WR.

J Urol. 1999 Sep;162(3 Pt 1):753-7.

PMID:
10458359
15.

Clinical features and prognosis of prostate cancer with high-grade prostatic intraepithelial neoplasia.

Lee D, Lee C, Kwon T, You D, Jeong IG, Hong JH, Ahn H, Kim CS.

Korean J Urol. 2015 Aug;56(8):565-71. doi: 10.4111/kju.2015.56.8.565. Epub 2015 Jul 24.

16.

Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma.

Cheng L, Jones TD, Lin H, Eble JN, Zeng G, Carr MD, Koch MO.

J Urol. 2005 Dec;174(6):2181-5.

PMID:
16280760
17.
18.

Implication of high grade intraepithelial neoplasia in adverse pathology after radical prostatectomy.

Sfoungaristos S, Perimenis P.

Prague Med Rep. 2012;113(2):156-65.

PMID:
22691286
19.

The impact of solitary and multiple positive surgical margins on hard clinical end points in 1712 adjuvant treatment-naive pT2-4 N0 radical prostatectomy patients.

Mauermann J, Fradet V, Lacombe L, Dujardin T, Tiguert R, Tetu B, Fradet Y.

Eur Urol. 2013 Jul;64(1):19-25. doi: 10.1016/j.eururo.2012.08.002. Epub 2012 Aug 10.

PMID:
22901983
20.

Early prostate-specific antigen relapse after radical retropubic prostatectomy: prediction on the basis of preoperative and postoperative tumor characteristics.

Graefen M, Noldus J, Pichlmeier U, Haese A, Hammerer P, Fernandez S, Conrad S, Henke R, Huland E, Huland H.

Eur Urol. 1999;36(1):21-30.

PMID:
10364651

Supplemental Content

Support Center